The evolving treatment landscape for HER2-positive metastatic breast cancer
The evolving treatment landscape for HER2-positive metastatic breast cancer
Navigating current treatment options for HER2-positive MBC: Patient journey 1
New tools can help tackle flawed decision-making process for HER2- patients
Personalisation of screening process could boost surival rates in breast cancer patients
Regular exercise prevents breast cancer
Troubling differences in the success rates of breast cancer treatment across different countries
NHS falling short in breast screening programmes
Breast cancer screening in older women
Implications for breast cancer treatment in those who are obese or diabetic.
The role of patient advocacy networks at the EBCC
Importance of a global health picture and a new form of capacity building for developing countries
Diagnostic and treatment resources must be transferred from developed to developing nations
The use of imaging in treatment strategies
Obesity and diabetes should be taken into account when planning breast cancer treatment
European breast screening programmes
Systematic and homogenous approach needed for the treatment of breast cancer patients
Consensus on the treatment of breast cancer and early intervention using endocrine therapy
Deaths from breast cancer fall in Europe, but unexplained differences between countries remain
Genetic testing can improve selection of women with ER positive breast cancer for ten rather than five years of hormonal therapy
A third of women might benefit from more frequent mammograms
Breast cancer screening in the UK: does it work?
Significant UK variations between hospitals in adverse outcomes for DCIS
EBCC 2014 key messages to doctors
Comment: Radiotherapy after mastectomy for breast cancer that has spread to just a few lymph nodes
Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer
Regular physical activity reduces breast cancer risk irrespective of age
Radiotherapy after mastectomy benefit for breast cancer that has spread to just a few lymph nodes